Bank Of America Corp Beyond Spring Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Beyond Spring Inc. stock. As of the latest transaction made, Bank Of America Corp holds 7,850 shares of BYSI stock, worth $15,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,850

Previous 7,850 -0.0%

Holding current value

$15,778

Previous $12,000 8.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.55 - $2.57 $232 - $385	-150 Reduced 1.88%	7,850 $12,000
Q2 2024 Aug 14, 2024	SELL	$1.76 - $3.6 $8,789 - $17,978	-4,994 Reduced 38.43%	8,000 $19,000
Q1 2024 May 15, 2024	BUY	$0.85 - $3.63 $4,017 - $17,159	4,727 Added 57.18%	12,994 $46,000
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.12 $89 - $148	133 Added 1.64%	8,267 $7,000
Q2 2023 Aug 14, 2023	SELL	$0.89 - $1.39 $23,350 - $36,468	-26,236 Reduced 76.33%	8,134 $9,000
Q1 2023 May 12, 2023	BUY	$1.06 - $3.05 $7,432 - $21,386	7,012 Added 25.63%	34,370 $38,000
Q4 2022 Feb 10, 2023	SELL	$0.56 - $2.61 $28,127 - $131,095	-50,228 Reduced 64.74%	27,358 $51,000
Q3 2022 Nov 14, 2022	SELL	$0.97 - $1.81 $13,873 - $25,888	-14,303 Reduced 15.57%	77,586 $77,000
Q2 2022 Aug 12, 2022	SELL	$1.13 - $2.66 $44,644 - $105,091	-39,508 Reduced 30.07%	91,889 $132,000
Q1 2022 May 16, 2022	BUY	$1.68 - $5.01 $68,604 - $204,588	40,836 Added 45.09%	131,397 $289,000
Q4 2021 Feb 08, 2022	BUY	$4.02 - $16.84 $145,061 - $607,671	36,085 Added 66.24%	90,561 $411,000
Q3 2021 Nov 15, 2021	BUY	$9.26 - $31.31 $137,270 - $464,139	14,824 Added 37.39%	54,476 $859,000
Q2 2021 Sep 13, 2021	BUY	$9.37 - $12.12 $371,539 - $480,582	39,652 New	39,652 $414,000

Others Institutions Holding BYSI

# of Institutions

Shares Held

5.68M

Call Options Held

200

Put Options Held

View Full List

About BeyondSpring Inc.

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $78.2M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

More about BYSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Beyond Spring Inc. Transaction History